Mar 10, 2025 7:00 am EDT NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
Jan 29, 2025 8:05 am EST NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
Jan 15, 2025 7:05 am EST NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
Jan 14, 2025 6:30 am EST Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
Jan 6, 2025 7:55 am EST NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Dec 11, 2024 8:05 am EST NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
